Abstract
The purpose of this visiongain report is to examine the commercial prospects
of nanotechnology in medicine - the fast-developing and increasingly lucrative
field of nanomedicine. Nanotechnology has great potential to benefit - even
revolutionise - the pharmaceutical, medical devices, diagnostics and imaging
sectors. Visiongain predicts that nanomedicine will exhibit strong growth in
all sectors from 2006-2011, leading to multi-billion dollar revenues. Key
technology platforms such as nanocrystals, nanotubes, dendrimers, fullerenes,
quantum dots and molecular scaffolding will drive that market expansion.
Nanomedicine 2006-2011 examines the nanomedical sector critically through
comprehensive primary and secondary research, including interviews with key
figures in industry and academia, reports and policy documents, nanotechnology
conference proceedings, business/industry news and consultation with bodies
promoting nanotechnology. Visiongain applied techniques such as financial
forecasting, SWOT analysis and qualitative projections to provide a
comprehensive market report with detailed analyses and informed opinion.
View Cart
